17^th International Conference on Alzheimer's disease and Dementia July 17-18, 2023 Edinburgh, Scotland

Alzheimers Disease 2023 is an important meeting where nervous system specialists and Neurology social orders talk about the fate of the Alzheimer's disease coordinated effort structures and hierarchical turn of events and advances of Neurology. Alzheimers disease 2023 is to convey an extraordinary program for trade of thoughts and definitive perspectives by driving researchers which covers the whole range of examination in Alzheimer's disease and Dementia and offers the multiracialism encounters of different therapy techniques. The 2 days meeting is a culmination to look forward for its illuminating conferences and research center from famous experts of the area and surprising feature meetings are facilitated by the best inside the business.

At Alzheimers Disease 2023, we are dedicated to raising awareness and advancing the understanding of Alzheimer's and Dementia diseases research. Don't miss this unique opportunity to network, connect with colleagues, and be a part of shaping the future of Neurology.

Target Audience:

• Researchers in the field of Alzheimer's disease and dementia

• Neurologists and psychiatrists specializing in Alzheimer's disease and dementia

• Healthcare professionals working in geriatric care

• Nurses, occupational therapists, and other allied health professionals working with Alzheimer's patients

• Policy makers and public health professionals working on Alzheimer's disease and dementia-related policies

• Non-profit organizations focused on Alzheimer's disease and dementia research, advocacy, and support

• Pharmaceutical and biotech companies involved in the development of Alzheimer's disease and dementia treatments

• Students and trainees pursuing degrees or training in neuroscience, geriatrics, or related fields

• Patients and caregivers affected by Alzheimer's disease and dementia who are interested in learning more about the latest research and treatment options.

• Academic researchers and professors involved in Alzheimer's disease and dementia research and education

• Government agencies and policymakers involved in funding and regulation related to Alzheimer's disease and dementia research and care

• Medical device manufacturers producing devices and technologies to assist with Alzheimer's disease and dementia care

• Caregivers and family members of those living with Alzheimer's disease and dementia who are seeking education and support resources

• Social workers and case managers working with older adults affected by Alzheimer's disease and dementia

• Representatives from advocacy groups and foundations focused on Alzheimer's disease and dementia research, education, and support.

• Data analysts and statisticians involved in analyzing data related to Alzheimer's disease and dementia research

• Journalists and media professionals covering news related to Alzheimer's disease and dementia research and care.

Features of Conference:

1. Keynote speeches from renowned experts in the field of Alzheimer's disease and Dementia

2. Oral and poster presentations of the latest research and developments in Alzheimer's disease and Dementia

3. Panel discussions and forums for the exchange of ideas and best practices related to Alzheimer's disease and Dementia care and research

4. Workshops and training sessions on topics such as caregiving, diagnosis, treatment, and prevention of Alzheimer's disease and Dementia

5. Exhibition of innovative technologies and products related to Alzheimer's disease and Dementia care

6. Networking opportunities for researchers, healthcare professionals, and industry representatives to share knowledge and collaborate on Alzheimer's disease and Dementia research and care

7. Opportunities for patient and caregiver involvement, including patient and caregiver panels and support groups

8. Continuing education credits for healthcare professionals

9. Access to the latest information on funding opportunities for Alzheimer's disease and Dementia research and care

10. A culturally diverse and inclusive conference program with a global perspective on Alzheimer's disease and Dementia research and care.

The Conference Registration Includes:

For In-Person Participants:

• Access (Entry) to all conference sessions, poster, and exhibition area: In-person participants will have the opportunity to attend all the sessions, including oral presentations, poster sessions, and access to the exhibition area.

• Conference kit: In-person participants will receive a conference kit, which typically includes a name tag, program booklet containing the schedule and session details, and an Abstract Book containing abstracts of the presentations.

• Refreshments: In-person participants will have access to 2 coffee breaks and lunch provided during the conference days. This allows participants to network and engage with other attendees during these breaks.

• Certificate accreditation: Participants will receive a certificate of accreditation from the Organizing Committee, which serves as proof of attendance at the conference.

For Virtual Participants:

• Access to all presentations: Virtual participants will have access to all the presentations, including oral presentations, which they can view remotely from their home or workplace. This allows them to engage with the content of the conference without physically attending.

• E-Abstract Book and Program: Virtual participants will receive an electronic version of the Abstract Book and the program. These materials will be provided in a digital format, allowing participants to review the abstracts and navigate through the conference schedule.

• E-Certificate for Presentation and Participation: Virtual participants who present at the conference virtually will receive an electronic certificate for their presentation. Additionally, all virtual participants will receive an e-certificate to acknowledge their participation in the conference.

We endeavor to make Alzheimers disease 2023 a fruitful culmination, with your assistance and magnificent conversations from both Alzheimer's disease and Dementia people group. Over the meeting, we promise you that you will encounter top grade offices and convenience at the meeting.

The Conference will feature many invigorating educational undertakings including various sheets, studios, enjoying bundle snacks, paper presentations, and coherent meetings by sensory system trained professionals and neurosurgeons from everywhere the country.

Awards: The conference offers awards to recognize outstanding research and presentation skills, including Best Young Researcher, Best Speaker, and Best Keynote Session.

Our Benefits:

• One on One Meeting with Famous Speakers from 40 Nations

• Live Streaming of the meeting

• Feature meetings by world's most well-known experts at Alzheimer's disease and Dementia research

• Top Enterprises Representation

• Provocative Symposia and studio

• Meeting studio in each and every huge country

• Choices for Best Banner Honor

• Noteworthy Youthful Specialist Grant

• Bunch Registration Benefits

Your participation and cooperation will be gigantically significant as we hope to support your expertise in the field of Neurological Disease!!

Track 1: Neurodegenerative Disease

Track 2: Dementia

Track 3: Alzheimer’s Disease

Track 4: Parkinson’s Disease

Track 5: Huntington’s Disease

Track 6: Multiple Sclerosis

Track 7: Prion Disease

Track 8: Batten Disease

Track 9: Vascular Dementia

Track 10:  Ataxia

Track 11: Amyotrophic lateral sclerosis or ALS

Track 12: Neurophysiology

Track 13: Neurological disorders

Track 14: Alzheimer’s disease Imaging

Track 15: Alzheimer’s disease and Type 2 Diabetes

Track 16: Animal Models and Translational Medicine

Track 17: Care Practice and Awareness

Track 18: Front Temporal Dementia

Track 19: Alzheimer’s disease Diagnosis

Track 20: Geriatrics and Cognitive Disorder

Track 21: Space Neuroscience

Track 22: Bipolar Disorder and Schizophrenia

Track 23: Psychiatry

Alzheimer's disease (AD) is a neurodegenerative infection that regularly starts steadily and consistently declines. It is the justification for 60-70% of cases of dementia. The most generally perceived early after effect is inconvenience in recalling continuous events. As the contamination moves, after effects can consolidate issues with language, bewilderment (counting really getting lost), mentality swings, loss of motivation, self-dismissal, and direct issues. As a singular's condition declines, they oftentimes pull out from family and society. One small step at a time, significant actual cycles are lost, ultimately provoking demise. Albeit the speed of development can contrast, the ordinary future following finding is three to nine years. Read More

ConferenceSeries hosted the event “16th International Conference on Alzheimer’s disease and Neurodegenerative Diseases” at Prague, Czech Republic during May 04-05, 2022. The conferences were organized with a focus on the themes “Neurodegenerative disease: Can you reduce the risk?” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.

The event proceedings were carried out through several Scientific-sessions and plenary lectures, ConferenceSeries would like to express a sincere thankfulness to all the Honourable guests and Keynote Speakers of 16th International Conference on Alzheimer’s disease and Neurodegenerative Diseases. We would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers of Alzheimers Disease - 2022.

Alzheimers Disease – 2022 committee would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers, Geoffrey-Burnstock University College Medical School,UK; Galina-Mindlin Mount Sinai, USA; Chethan-P-Venkatasubba-Rao Baylor College of Medicine, USA; Peter-Silburn The University of Queensland, Australia; Dionisio-Figueiredo Hospital de Urgencia Otavio Lage, Brazil; Alessandro-Morelli University of Genova, Italy have given a wonderful talk which makes allows the delegates and other attendees to gain the knowledge about main course of the event.

Alzheimers disease – 2022 Organizing Committee would like to thank the Moderator of the conference, Chaka Fattah CEO & Founder Fattah Neuroscience Global Advisors Philadelphia, US, who contributed a lot for the smooth functioning of this event and for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support.

ConferenceSeries also took the privilege of felicitating Alzheimer’s disease – 2022 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events. We would also like to thank Chairs and Co-chairs of the conference, Chethan-P-Venkatasubba-Rao Baylor College of Medicine, USA; ; Galina-Mindlin Mount Sinai, USA; Dionisio-Figueiredo Hospital de Urgencia Otavio Lage, Brazil for a being a great support for our event to be a grand success.

A series of lectures by distinguished professionals discussed the recent trends and issues in inter-disciplinary Rheumatology and its technical advancements.

Save your dates for the most awaited event of 2023

With a great response and feedback which we received from participants and supporters from Alzheimers disease – 2022, we are proud to announce our upcoming conferences in the Series 17th International Conference on Alzheimer's disease and Dementia on July 17-18, 2023 in London, UK with the theme of Aims to raise awareness of Alzheimer’s disease and Dementia.

Some of our conference images are as follows:

The main aim of this conference is to solicit the gracious presence of our honourable, to the upcoming conference “17th International Conference on Alzheimer's disease and Dementia” that is going to be held during July 17-18, 2023 in London, UK, to share and exchange their knowledge. 

It is an International platform for business delegates, B2B meetings, poster presentations, workshops, symposia, networking and more. It will offer a platform wherein you can ensure enormous exposure and networking by exhibiting products and services. Grab the opportunities, and share your innovative ideas, new technologies and Recent researches.

Alzheimers Disease - 2023 witnesses an amalgamation of peerless speakers who enlightened the gathering with their contribution towards the prevention of Alzheimer related difficulties, its effects and treatment on Alzheimer.

For being a Experts in Neurologist and Geriatricians, we hope that this platform gives knowledge and new updates by undergoing with the several interactive sessions to encourage the exchange of innovative ideas in the field of Neurology and its advancements, in that all the session talks are consider to be a great talks which makes the delegates, exhibitor, collaborators and other speakers feels so much interesting.

Being a significant expert in this area we would like to Invite you as an International Organizing Committee Members, Speakers, Keynote speakers, Young Research forum, Sponsors and Exhibitor, etc. for Alzheimers disease-2023 . Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Neurology, therapies and effective diagnostics and share the cross-cultural experiences of various principles and practices.

The centre of the activity of Alzheimers disease-2023 is to produce the clear visual definition by undergoing with Oral Presentation, Poster presentation, Workshop, Exhibition, networking and interacting session

With the feedback from your renowned Speakers, we have added some of the new Session tracks that needs to be focused such as such as Neurophysiology, Neurological disorders, Alzheimer’s disease Imaging, Alzheimer’s disease and Type 2 Diabetes, Animal Models and Translational Medicine Front Temporal Dementia, Neurodegenerative Disease, Alzheimer’s disease Diagnosis, Dementia Geriatrics and Cognitive Disorder, Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease.

With the great support we have successfully completed and we are expecting huge response and support from the Alzheimer’s & Neurology Doctors, neurologists, geriatric psychiatrists, and pediatric neurophysiologists Professionals, Young researchers, Students, Delegates, Directors and other Alzheimer’s & Dementia related companies to have your gracious presence at Alzheimers disease-2023 on July 17-18, 2023 in London, UK to make this congress a great successful event of the year 2023.

Join our team Alzheimers disease-2023 at this beautiful city of London, UK and let’s make this professional gathering a Great success.

Contact us:

Tomson Louis

Program Manager

Alzheimers disease-2023

Website: https://alzheimersdisease.neuroconferences.com/